Cardiac involvement in hereditary myopathy with early respiratory failure

Neurology

Volumn 87, Issue 10, 2016, Pages 1031-1035

  Steele, Hannah E ^a   Harris, Elizabeth ^a   Barresi, Rita ^a   Marsh, Julie ^a   Beattie, Anna ^b   Bourke, John P ^b   Straub, Volker ^a   Chinnery, Patrick F ^c,d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISOPROLOL; DESMIN; LISINOPRIL; CONNECTIN; TTN PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; ASYMPTOMATIC DISEASE; ATRIAL FIBRILLATION; CARDIOVASCULAR MAGNETIC RESONANCE; CATHETER ABLATION; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DIASTOLIC DYSFUNCTION; ELECTROCARDIOGRAM; FEMALE; HEART CONDUCTION; HEART PALPITATION; HEREDITARY MYOPATHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MALE; MIDDLE AGED; MISSENSE MUTATION; MYOPATHY; NONISCHEMIC CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE SCANNER; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SINUS BRADYCARDIA; SUPRAVENTRICULAR PREMATURE BEAT; SUPRAVENTRICULAR TACHYCARDIA; SYSTOLIC DYSFUNCTION; TREATMENT RESPONSE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WESTERN BLOTTING; YOUNG ADULT; CARDIAC MUSCLE; DIAGNOSTIC IMAGING; ELECTROCARDIOGRAPHY; GENETIC DISORDER; GENETICS; HEART; HEART ARRHYTHMIA; MUSCLE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; X-RAY COMPUTED TOMOGRAPHY;

ADOLESCENT; ADULT; ARRHYTHMIAS, CARDIAC; BLOTTING, WESTERN; COHORT STUDIES; CONNECTIN; ELECTROCARDIOGRAPHY; FEMALE; GENETIC DISEASES, INBORN; HEART; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCULAR DISEASES; MUTATION, MISSENSE; MYOCARDIUM; PHENOTYPE; RESPIRATORY INSUFFICIENCY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84986184238     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000003064     Document Type: Article

References (39)

1. Majounie E, Renton AE, Mok K, et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 2012;11:323-330
2. Mahoney CJ, Beck J, Rohrer JD, et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012;135:736-750
3. Byrne S, Elamin M, Bede P, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 2012;11:232-240
4. Chio A, Borghero G, Restagno G, et al. Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 2012;135:784-793
5. Murray ME, DeJesus-Hernandez M, Rutherford NJ, et al. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol 2011;122:673-690
6. Snowden JS, Harris J, Richardson A, et al. Frontotemporal dementia with amyotrophic lateral sclerosis: a clinical comparison of patients with and without repeat expansions in C9orf72. Amyotroph Lateral Scler Frontotemporal Degener 2013;14:172-176
7. Stewart H, Rutherford NJ, Briemberg H, et al. Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathol 2012;123:409-417
8. Irwin DJ, McMillan CT, Brettschneider J, et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2013;84:163-169
9. Sabatelli M, Conforti FL, Zollino M, et al. C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population. Neurobiol Aging 2012;33:1848.e15-1848.e20
10. Cooper-Knock J, Hewitt C, Highley JR, et al. Clinicopathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 2012;135:751-764
11. Ratti A, Corrado L, Castellotti B, et al. C9ORF72 repeat expansion in a large Italian ALS cohort: evidence of a founder effect. Neurobiol Aging 2012;33:2528.e7-2528.e14
12. Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD. Prognosis and epidemiology of amyotrophic lateral sclerosis: analysis of a clinic population, 1997-2011. Neurol Clin Practice 2013;3:313-320
13. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803-1809
14. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245-256
15. Wang X, Shen Y, Chen W. Progress in frontotemporal dementia research. Am J Alzheimers Dis Other Demen 2013;28:15-23
16. Boeve BF, Boylan KB, Graff-Radford NR, et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 2012;135:765-783
17. Hodges J. Familial frontotemporal dementia and amyotrophic lateral sclerosis associated with the C9ORF72 hexanucleotide repeat. Brain 2012;135:652-655
18. Alberici A, Cottini E, Cosseddu M, Borroni B, Padovani A. Suicide risk in frontotemporal lobe degeneration: to be considered, to be prevented. Alzheimer Dis Assoc Disord 2012; 26:194-196
19. Landqvist Waldo M, Santillo AF, Gustafson L, Englund E, Passant U. Somatic complaints in frontotemporal dementia. Am J Neurodegener Dis 2014;3:84-92
20. Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257-268
21. Garcia-Redondö A, Dols-Icardo O, Rojas-Garcia R, et al. Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide. Hum Mutat 2013;34:79-82
22. Borghero G, Pugliatti M, Marrosu F, et al. Genetic architecture of ALS in Sardinia. Neurobiol Aging 2014;35:2882. e7-2882.e12
23. Montuschi A, Iazzolino B, Calvo A, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 2015;86: 168-173
24. Williams JR, Fitzhenry D, Grant L, Martyn D, Kerr DA. Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database. BMC Neurol 2013;13:160
25. Chio A, Logroscino G, Traynor BJ, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013;41: 118-130
26. Freer C, Hylton T, Jordan HM, Kaye WE, Singh S, Huang Y. Results of Florida's Amyotrophic Lateral Sclerosis Surveillance Project, 2009-2011. BMJ Open 2015;5: e007359
27. Valle J, Roberts E, Paulukonis S, Collins N, English P, Kaye W. Epidemiology and surveillance of amyotrophic lateral sclerosis in two large metropolitan areas in California. Amyotroph Lateral Scler Frontotemporal Degener 2015;16:209-215
28. Cooper-Knock J, Shaw PJ, Kirby J. The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype. Acta Neuropathol 2014;127:333-345
29. van Rheenen W, van Blitterswijk M, Huisman MH, et al. Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology 2012;79: 878-882
30. Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003; 60:813-819
31. Magnus T, Beck M, Giess R, Puls I, Naumann M, Toyka KV. Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve 2002;25:709-714
32. Hu WT, Shelnutt M, Wilson A, et al. Behavior matters: cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One 2013;8:e57584
33. Ziegler LH. Psychotic and emotional phenomena associated with amyotrophic lateral sclerosis. Arch Neurol Psychiatry 1930;24:930-936
34. Finlayson MH, Martin JB. Cerebral lesions in familial amyotrophic lateral sclerosis and dementia. Acta Neuropathol 1973;26:237-246
35. Devenney E, Vucic S, Hodges JR, Kiernan MC. Motor neuron disease-frontotemporal dementia: a clinical continuum. Expert Rev Neurother 2015;15:509-522
36. Pasinelli P, Brown RH. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci 2006;7:710-723
37. Conforti FL, Barone R, Fermo SL, et al. Sporadic motor neuron disease in a familial novel SOD1 mutation: incomplete penetrance or chance association? Amyotroph Lateral Scler 2011;12:220-222
38. Jones CT, Brock DJ, Chancellor AM, Warlow CP, Swingler RJ. Cu/Zn superoxide dismutase (SOD1) mutations and sporadic amyotrophic lateral sclerosis. Lancet 1993;342:1050-1051
39. Galimberti D, Arosio B, Fenoglio C, et al. Incomplete penetrance of the C9ORF72 hexanucleotide repeat expansions: frequency in a cohort of geriatric non-demented subjects. J Alzheimers Dis 2014;39:19-22